학술논문
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
Document Type
Article
Author
Zhao, Li; Wang, Xiongbiao; Wang, Xuefen; Wang, Dexi; Li, Xiangyang; Peng, Yiqiang; Liang, Yongjie; Liu, Hua; Xiao, Zuke; Lv, Xiaoju; Wu, Shiman; Dai, Yuanrong; Huang, Yijiang; Hu, Zhenghong; Qiu, Chen; Li, Xi; Zhang, Suiyang; Li, Wenpu; Liu, Shuang; Shi, Yi; Xiong, Chang; Kuang, Jiulong; Xiu, Qingyu; Cui, Shehuai; Li, Jianguo; Lin, Qichang; Huang, Wenxiang; Wan, Yixin; Qimanguli; Shen, Ce; Xiao, Yi; Wu, Xiaoju; Chuang, Yin Ching; Perng, Wann Cherng; Tsao, Shih-Ming; Hsu, Jeng-Yuan; Wang, Chin-Chou; Wang, Jen-Hsien; Yeh, Pen-Fang; Lin, His-Hsun; Kuo, P.H.; Lin, Ming-Shian; Su, Wei-Juin; Yuan, Jinyi; Mo, Biwen; Ma, Zhuang; Lv, Yuan; Cheng, Shih-Lung; Yang, Yanping; Tong, Zhaohui; Wu, Renguang; Sun, Shenghua; Cao, Zhaolong; Wu, Jufang; Zhu, Demei; Chang, Liwen; Zhang, Yingyuan
Source
In Journal of Microbiology, Immunology and Infection February 2019 52(1):35-44
Subject
Language
ISSN
1684-1182